Editorial: Purinergic Signaling 2020: the State-of-The-Art commented by the members of the Italian Purine Club

Publication date

2025-09-19T08:46:50Z

2025-09-19T08:46:50Z

2021-09-14

2025-09-19T08:46:50Z

Abstract

The “purinergic signaling” term was coined in 1972 by Geoffrey Burnstock Burnstock et al. after demonstrating that adenosine 5’-triphosphate (ATP) is a transmitter in nonadrenergic, noncholinergic inhibitory nerves innervating the guinea-pig taenia coli (Burnstock et al., 1966). This signaling system, which is ubiquitously expressed in every organ and system of the body, comprises various ecto-, soluble and intracellularly localized enzymes, nucleoside transporters, and G protein-coupled and ligand-gated cation channel receptors. Through the purinergic signaling system cells can maintain basal adenine and guanine-based purines at certain steady-state levels, thereby contributing to preserve the purines-dependent cellular homeostasis.

Document Type

Published version


Article

Language

English

Publisher

Frontiers Media

Related items

Reproducció del document publicat a: https://doi.org/10.3389/fphar.2021.768923

Frontiers in Pharmacology, 2021, vol. 12

https://doi.org/10.3389/fphar.2021.768923

Recommended citation

This citation was generated automatically.

Rights

cc-by (c) Ciruela, F. et al., 2021

http://creativecommons.org/licenses/by/4.0/